Core Scientific, Inc. (NASDAQ:CORZ) Shares Purchased by Legal & General Group Plc

Legal & General Group Plc raised its stake in shares of Core Scientific, Inc. (NASDAQ:CORZ - Free Report) by 30.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 194,368 shares of the company's stock after acquiring an additional 45,189 shares during the period. Legal & General Group Plc owned about 0.07% of Core Scientific worth $2,731,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of the company. Sanctuary Advisors LLC raised its stake in shares of Core Scientific by 130.1% during the 3rd quarter. Sanctuary Advisors LLC now owns 34,527 shares of the company's stock valued at $409,000 after purchasing an additional 19,522 shares during the period. JPMorgan Chase & Co. increased its stake in Core Scientific by 48.0% in the third quarter. JPMorgan Chase & Co. now owns 437,812 shares of the company's stock valued at $5,192,000 after acquiring an additional 142,068 shares during the last quarter. Wealth Enhancement Advisory Services LLC raised its position in Core Scientific by 25.6% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 98,077 shares of the company's stock valued at $1,378,000 after purchasing an additional 20,000 shares in the last quarter. ORG Wealth Partners LLC lifted its stake in Core Scientific by 0.3% during the fourth quarter. ORG Wealth Partners LLC now owns 8,986,651 shares of the company's stock worth $126,262,000 after purchasing an additional 26,649 shares during the last quarter. Finally, FNY Investment Advisers LLC boosted its holdings in shares of Core Scientific by 35.8% in the 4th quarter. FNY Investment Advisers LLC now owns 190,747 shares of the company's stock worth $2,679,000 after purchasing an additional 50,275 shares in the last quarter.

Insider Activity at Core Scientific

In related news, Director Todd A. Becker sold 134,250 shares of Core Scientific stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $10.75, for a total transaction of $1,443,187.50. Following the completion of the transaction, the director now directly owns 195,687 shares in the company, valued at $2,103,635.25. The trade was a 40.69 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Jordan Levy acquired 62,500 shares of the firm's stock in a transaction that occurred on Thursday, March 6th. The shares were bought at an average cost of $8.01 per share, for a total transaction of $500,625.00. Following the purchase, the director now owns 306,887 shares of the company's stock, valued at approximately $2,458,164.87. The trade was a 25.57 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.40% of the stock is owned by insiders.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the stock. Compass Point lowered their price objective on shares of Core Scientific from $26.00 to $20.00 and set a "buy" rating for the company in a report on Tuesday, February 25th. HC Wainwright reissued a "buy" rating and set a $17.00 price objective on shares of Core Scientific in a research report on Tuesday, March 11th. Craig Hallum started coverage on Core Scientific in a research report on Tuesday, January 21st. They set a "buy" rating and a $24.00 price objective on the stock. Keefe, Bruyette & Woods started coverage on Core Scientific in a research note on Monday, January 27th. They issued an "outperform" rating and a $22.00 price target on the stock. Finally, Cantor Fitzgerald cut their price objective on shares of Core Scientific from $24.00 to $21.00 and set an "overweight" rating for the company in a research report on Thursday, February 27th. Fifteen investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Buy" and an average target price of $19.07.

Core Scientific Stock Up 10.4 %

NASDAQ:CORZ traded up $0.78 during trading hours on Friday, reaching $8.31. 13,719,523 shares of the company's stock were exchanged, compared to its average volume of 12,688,100. Core Scientific, Inc. has a 1-year low of $2.88 and a 1-year high of $18.63. The firm has a market capitalization of $2.45 billion, a price-to-earnings ratio of -1.54 and a beta of 6.80. The company has a 50-day moving average of $8.29 and a 200 day moving average of $12.37.

Core Scientific (NASDAQ:CORZ - Get Free Report) last posted its quarterly earnings data on Wednesday, February 26th. The company reported ($0.01) EPS for the quarter, beating the consensus estimate of ($0.10) by $0.09. The company had revenue of $94.93 million for the quarter, compared to analysts' expectations of $97.07 million. Research analysts forecast that Core Scientific, Inc. will post 0.52 EPS for the current fiscal year.

Core Scientific Company Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.